Search research articles
Contact Us
Filters
Showing results (281-290 of 377) with videos related to
Page
of 38
Sort By:
Rheumatology (Oxford, England)
|
March 16, 2021
Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre study
Amandine Weill, Julie Delyon, Vincent Descamps, et al.
European Radiology
|
March 5, 2009
Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring
F Staub, C Tournoux-Facon, J Roumy, et al.
British Journal of Haematology
|
October 10, 2022
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study)
Lydia Roy, Jean-Claude Chomel, Joëlle Guilhot, et al.
Leukemia & Lymphoma
|
July 13, 2017
Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria
Guillemette Fouquet, Kym Ie Snell, Stéphanie Guidez, et al.
Diagnostic Pathology
|
May 29, 2020
Clinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide study
Elodie Miquelestorena-Standley, Charlotte Jaulerry, Marie-Christine Machet, et al.
Blood Advances
|
July 2, 2025
Asciminib for relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
Mathilde Chanut, Aurélie Cabannes-Hamy, Marie Balsat, et al.
Hemasphere
|
September 8, 2025
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM study
Corentin Orvain, Suzanne Tavitian, Clémence Mediavilla, et al.
Acta Neuropathologica Communications
|
August 14, 2021
Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions
Arnault Tauziède-Espariat, Aurore Siegfried, Yvan Nicaise, et al.
Journal of Oncology
|
January 12, 2019
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
Claire Mignard, Aurélie Deschamps Huvier, André Gillibert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2020
Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas
Eve Maubec, Marouane Boubaya, Peter Petrow, et al.
Page
of 38
Search research articles
Search
Showing results (281-290 of 377) with videos related to
Sort By:
Page
of 38
Rheumatology (Oxford, England)
|
March 16, 2021
Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre study
Amandine Weill, Julie Delyon, Vincent Descamps, et al.
European Radiology
|
March 5, 2009
Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring
F Staub, C Tournoux-Facon, J Roumy, et al.
British Journal of Haematology
|
October 10, 2022
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study)
Lydia Roy, Jean-Claude Chomel, Joëlle Guilhot, et al.
Leukemia & Lymphoma
|
July 13, 2017
Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria
Guillemette Fouquet, Kym Ie Snell, Stéphanie Guidez, et al.
Diagnostic Pathology
|
May 29, 2020
Clinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide study
Elodie Miquelestorena-Standley, Charlotte Jaulerry, Marie-Christine Machet, et al.
Blood Advances
|
July 2, 2025
Asciminib for relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
Mathilde Chanut, Aurélie Cabannes-Hamy, Marie Balsat, et al.
Hemasphere
|
September 8, 2025
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM study
Corentin Orvain, Suzanne Tavitian, Clémence Mediavilla, et al.
Acta Neuropathologica Communications
|
August 14, 2021
Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions
Arnault Tauziède-Espariat, Aurore Siegfried, Yvan Nicaise, et al.
Journal of Oncology
|
January 12, 2019
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
Claire Mignard, Aurélie Deschamps Huvier, André Gillibert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2020
Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas
Eve Maubec, Marouane Boubaya, Peter Petrow, et al.
Page
of 38